Peer-led HIV prevention choices for women in Uganda
Peer-led Dynamic Choice HIV Prevention for Women at Elevated HIV Risk in Uganda
['FUNDING_R01'] · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · NIH-11415579
This project gives women at higher risk of HIV in Uganda peer support and a menu of prevention options they can choose and switch between over time.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO (nih funded) |
| Locations | 1 site (SAN FRANCISCO, UNITED STATES) |
| Trial ID | NIH-11415579 on ClinicalTrials.gov |
What this research studies
If you join, peer leaders will help explain and offer different HIV prevention options—like pills, long-acting injections, or a vaginal ring—and you can pick the option that fits your life and change it later. You will be offered the choice of clinic or community-based visits and support to help with starting and staying on prevention. The approach was developed with local community advisers and builds on earlier trials that increased how long women stayed covered by prevention products. The team is tailoring the program to better reach women working in venues and others at elevated risk in Uganda.
Who could benefit from this research
Good fit: Women in Uganda who are HIV-negative and face elevated risk of HIV (for example, venue-based workers or others with ongoing exposure) would be the ideal participants.
Not a fit: People living with HIV, men, or women with very low HIV exposure who do not need biomedical prevention options would not benefit from this prevention-focused program.
Why it matters
Potential benefit: If successful, this could help more women stay protected from HIV by making prevention easier to access and use over time.
How similar studies have performed: Prior randomized trials of the Dynamic Choice approach more than doubled the time women were covered by prevention products compared to standard services, and this work adapts that model to better reach high-risk women.
Where this research is happening
SAN FRANCISCO, UNITED STATES
- UNIVERSITY OF CALIFORNIA, SAN FRANCISCO — SAN FRANCISCO, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: KOSS, CATHERINE ANNE STIMETS — UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
- Study coordinator: KOSS, CATHERINE ANNE STIMETS
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Acquired Immune Deficiency Syndrome Virus, Acquired Immunodeficiency Syndrome Virus